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Abstract 
INTRODUCTION: The novel coronavirus (COVID-19) is a global pandemic. Although the main 
clinical manifestation of COVID-19 is respiratory involvement, there is evidence suggesting the 
neuroinvasive potential of COVID-19. There are limited reports of neurological complications of 
COVID-19 infection in the literature. Herein, we aim to describe 2 members of a family affected 
by COVID-19, presenting with ascending paresthesia with the final diagnosis of Guillain-Barré 
syndrome. CASE REPORT: A 38-year-old man presented with a history of ascending paresthesia 
and bilateral facial droop since 5 days before admission. The medical history was positive for flu-
like symptoms affecting all the members of his family. The neurological examination was notable 
for bilateral peripheral facial paralysis, generalized areflexia, and derceased sensation in distal 
limbs. The cerebrospinal fluid analysis revealed an albuminocytologic dissociation. In addition, 
the electromyography-nerve conduction study findings were suggestive of acute axonal-
demyelinating polyneuropathy. Meanwhile the patient was treated with a diagnosis of Guillain-
Barré syndrome, his 14-year-old daughter presented with a history of progressive paresthesia and 
weakness. Similar to her father, the paraclinical evaluations were consistent with Guillain-Barré 
syndrome. Taking into account clinical findings and the outbreak of COVID-19, the suspicion of 
COVID-19 was proposed. Eventually, on the basis of throat swab samples stand on polymerase 
chain reaction, the patients were diagnosed with COVID-19. CONCLUSION: Our cases revealed 
the familial occurrence of Guillain-Barré syndrome after COVID-19 infection. The authors 
emphasize neurological complications of COVID-19. 
 
